Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever [Phase 3]
This Phase 3 trial update identifies factors that predict the efficacy of grass pollen injected allergen immunotherapy for seasonal allergic…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Azelastine Allergen Chamber - Onset of Action Study [Phase 2]
Phase 2 clinical trial updating on onset of action for azelastine in an allergen chamber for seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis. [Phase 4]
Phase 4 trial update investigating methylprednisolone injections for birch pollen–induced allergic rhinitis (hay fever).
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis [Phase 3]
A multicenter phase 3 randomized trial evaluating bioequivalence of monometasone furoate nasal spray in seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Study of CM310 in Subjects With Seasonal Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial update for CM310 in subjects with seasonal allergic rhinitis is provided, with status not disclosed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating drug-drug interaction and relative bioavailability between a fixed-dose combination nasal spray (Azela…
-
FDA approval · 2023-11-27FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium from Dr. Reddy's Laboratories Limited, representing an additional approva…
-
FDA approval · 2023-11-21FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare Inc.'s Montelukast Sodium supplemental application for the generic product, enabling its labeling and market …
-
FDA approval · 2023-11-15FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) from Haleon US Holdings LLC.
-
FDA approval · 2023-11-09FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved Bayer’s supplemental application for Claritin-D 24 Hour, adding a 24-hour loratadine and pseudoephedrine sulfate formulation. T…
-
FDA approval · 2023-10-02FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals, LLC's supplemental application for Montelukast Sodium, a generic product under an ANDA.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma [Phase 3]
A Phase 3 trial of grass pollen immunotherapy using a cluster regime for seasonal rhinitis and asthma has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Repeat Nasal Allergen Challenge [Phase 2]
Phase 2 clinical trial update for a repeat nasal allergen challenge in hay fever (seasonal allergic rhinitis) conducted by Imperial College …
-
FDA approval · 2023-08-08FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Fluticasone Propionate by Padagis Israel Pharmaceuticals Ltd, indicating an approved update to a…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis. [Phase 3]
A Phase 3 trial assessing the efficacy and safety of Azelastine + Mometasone nasal spray and Momet Rino Advance nasal spray as monotherapy i…
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis [Phase 3]
Phase 3 randomized trial in seasonal allergic rhinitis completed; results not described in the snippet.
-
FDA approval · 2023-06-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental ANDA for Montelukast Sodium from Unichem Pharmaceuticals (USA), Inc., adding a generic Montelukast Sodium produc…
-
FDA approval · 2023-06-26FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approves a supplemental application for montelukast sodium from Lannett Company, Inc., under ANDA200405, authorizing an updated generic …
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients [Phase 3]
A Phase 3 clinical trial comparing Fluticasone Propionate Nasal Spray 50 mcg/Actuation to Flonase in seasonal allergic rhinitis was terminat…
-
EMA approval · 2023-06-01EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf
The EMA has authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria indications in the European Union.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis [Phase 2]
Phase 2 clinical trial update for IRL201104 in seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Dymista Allergen Chamber - Onset of Action Study [Phase 4]
Phase 4 clinical trial update for Dymista in seasonal allergic rhinitis; study completed with results posted.
-
FDA approval · 2023-03-09FDA Approved: RUGBY MOMETASONE FUROATE NASAL — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Mometasone Furoate Nasal (mometasone furoate) submitted by Rugby Laboratories.
-
FDA approval · 2022-12-27FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy containing fexofenadine hydrochloride, submitted by Chattem, Inc., to…
-
FDA approval · 2022-08-30FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Lifestar Pharma LLC)
FDA approves Lifestar Pharma LLC's phenylephrine hydrochloride under an Original Application (ANDA). This approval introduces a generic phen…